跳至主要内容
临床试验/JPRN-UMIN000014819
JPRN-UMIN000014819已完成4 期

Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER): A Multicenter, Double-blind, Randomized, Placebo-controlled Trial - Cholecalciferol Supplementation for Anemia and Mineral and Bone Disorder in Hemodialysis Patients (CHAMBER)

Osaka University Graduate School of Medicine Department of Comprehensive Kidney Disease Research0 个研究点目标入组 90 人开始时间: 2014年8月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) On treatment with epoetin beta pegol as ESA 2) On supplementation with native vitamin D 3) Hypercalcemia (>=10.5 mg/dL ofcorrected serum calcium) 4) On treatment with intravenous iron agents 5) Judged as ineligible to the randomized study by the investigators

研究者

发起方
Osaka University Graduate School of Medicine Department of Comprehensive Kidney Disease Research

相似试验